Drug intelligence / Profile preview

PuraGold

Development stage
Unknown
Lead developer
PuraPharm
Modality
Therapeutic Vaccines → Vaccines & Immunotherapeutics
Administration
Oral
01

Overview

PuraGold (also known as Jin Lingzhi) is a standardized herbal and fungal extract developed by PuraPharm for the treatment of early-stage Parkinson's disease. The formulation is a complex mixture derived from multiple Ganoderma species, including *Ganoderma lucidum*, *Ganoderma sinense*, *Ganoderma nigrolucidum*, *Ganoderma tropicum*, *Ganoderma applanatum*, and *Coriolus versicolor*. It is administered orally in 400mg capsules. The therapeutic mechanism involves neuroprotection through the inhibition of microglial activation and the reduction of neuroinflammation, which helps protect dopaminergic neurons from oxidative stress. Additionally, it is thought to modulate the immune system and regulate mitochondrial function. Clinical research has included a randomized, double-blind, placebo-controlled trial involving 300 patients with idiopathic Parkinson's disease to evaluate its disease-modifying potential.

Brand names
PuraGoldJin Lingzhi
Other names
Standardized Lingzhi extractStandardized Ganoderma extract金靈芝

Beyond the preview

Go deeper on PuraGold.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on PuraGold.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call